Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

9.74
-0.1000-1.02%
Post-market: 9.740.00000.00%17:16 EDT
Volume:130.07K
Turnover:1.26M
Market Cap:3.01B
PE:28.73
High:9.80
Open:9.64
Low:9.52
Close:9.84
Loading ...

Alvotech Expects Minimal Impact from U.S. Tariffs on Pharmaceuticals

TIPRANKS
·
08 May

Alvotech Sees Minimal Impact From Potential US Drug Tariffs in 2025

MT Newswires Live
·
07 May

Stock Track | Alvotech Soars 5.02% Pre-market on Minimal Impact Expected from Potential U.S. Tariffs

Stock Track
·
07 May

Stock Track | Alvotech Surges 5.02% Pre-Market on Minimal Impact Expected from Potential U.S. Tariffs

Stock Track
·
07 May

Stock Track | Alvotech Surges 5% Pre-market as U.S. Tariffs Expected to Have Minimal Impact on 2025 Revenues

Stock Track
·
07 May

BRIEF-Alvotech Sees Minimal Impact On 2025 Revenues From U.S. Tariffs

Reuters
·
07 May

Stock Track | Alvotech Plunges 5.90% Pre-market on U.S. Tariff Concerns for Icelandic Imports

Stock Track
·
07 May

Stock Track | Alvotech Plunges 5.90% Pre-market on Potential 10% U.S. Tariff on Icelandic Imports

Stock Track
·
07 May

Alvotech Sa - a 10% Tariff on Pharmaceuticals Would Raise Cost of Biosimilars From Alvotech Imported to U.S. for Customers by Less Than 1% of Alvotech's Expected Total Product Revenues in 2025

THOMSON REUTERS
·
07 May

Alvotech SA expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
06 May

Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires Live
·
05 May

Alvotech’s SELARSDI Gains FDA Approval for Interchangeability with Stelara

TIPRANKS
·
05 May

Teva, Alvotech Get FDA Approval for Selarsdi's Interchangeablity With Stelara

MT Newswires Live
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi™ (Ustekinumab-Aekn) With Stelara® (Ustekinumab)

THOMSON REUTERS
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

GlobeNewswire
·
05 May

Teva, Alvotech announce FDA approval of interchangeability for SELARSDI

TIPRANKS
·
05 May

Alvotech Sa - Teva, Alvotech Announce FDA Approval of Interchangeability for Selarsdi (Ustekinumab-Aekn) With Stelara (Ustekinumab)

THOMSON REUTERS
·
05 May

Alvotech Sa - Selarsdi Approved for All Indications Matching Stelara

THOMSON REUTERS
·
05 May

Alvotech Sa - Selarsdi Indicated for Psoriasis, Arthritis, Crohn's, Ulcerative Colitis

THOMSON REUTERS
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi™ (Ustekinumab-Aekn) With Stelara® (Ustekinumab)

THOMSON REUTERS
·
05 May